The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.

Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.

View all videos

ASCO 2020

American Society of Clinical Oncology Annual Meeting
ASCO 2020 Virtual 29th – 31st May

It’s been 2 weeks since @myESMO World Congress on #GICancer ended but don’t worry, there’s still more expertly crafted medical content soon to be posted on 👉http://VJOncology.com👈
@VJOncology @WCGIC #WorldGI2020 #CRCsm #Pancsm #GCsm #OncoAlert

VIDEO: SAFIR02-IMMUNO: PDL1 copy number changes predicts checkpoint blockade inhibitor efficacy in mBC w/ Thomas Bachelot w/ @CLCCLeonBerard: http://ow.ly/5ZDZ50AuLdP

@VJOncology @myESMO #BCsm #VirtualMeeting #ESMOBreast20 #OncoAlert @OncoAlert #BreastCancer #ImmunoOnc

You think it’s dull to read tweets about the @myESMO 🤝 @OncoAlert 🚨 “Social Media & Virtual Meetings in the #COVID19 Era” survey?
Consider yourself lucky bc instead you can watch (‼️) #OncoAlert mastermind @weoncologists explain the whole thing in this (👇) @VJOncology video! https://twitter.com/vjoncology/status/1283072388209483777

VJ Oncology@VJOncology

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

#PYROTINIB EN #NSCLC AVANZADO HER2-MUTADO, PREVIO TRATAMIENTO CON #QUIMIOTERAPIA
https://www.esmo.org/oncology-news/pyrotinib-in-her2-mutated-advanced-nsclc-previously-treated-with-chemotherapy?hit=some

@Dunson30612519 @school_latin @GOncologia @ManuelDomine @MarianaBrandao0 @OPENoncology @susanahprieto @VJOncology @jillfeldman4 @dokter_onkologi @AnnaFaragoMD @myESMO https://twitter.com/myESMO/status/1282895118773686275

ESMO - Eur. Oncology@myESMO

Pyrotinib in HER2-mutated advanced #NSCLC previously treated with #chemotherapy: Promising antitumour activity & acceptable safety profile in #cancerpatients. A global, multicentre, randomised Ph3 III planned 🔎 http://ow.ly/4RcO50AwuT7 #oncologynews #cancerresearch #lcsm

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

Load More

ASCO 2020

American Society of Clinical Oncology Annual Meeting
ASCO 2020 Virtual 29th – 31st May

The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.

Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.

View all videos

It’s been 2 weeks since @myESMO World Congress on #GICancer ended but don’t worry, there’s still more expertly crafted medical content soon to be posted on 👉http://VJOncology.com👈
@VJOncology @WCGIC #WorldGI2020 #CRCsm #Pancsm #GCsm #OncoAlert

VIDEO: SAFIR02-IMMUNO: PDL1 copy number changes predicts checkpoint blockade inhibitor efficacy in mBC w/ Thomas Bachelot w/ @CLCCLeonBerard: http://ow.ly/5ZDZ50AuLdP

@VJOncology @myESMO #BCsm #VirtualMeeting #ESMOBreast20 #OncoAlert @OncoAlert #BreastCancer #ImmunoOnc

You think it’s dull to read tweets about the @myESMO 🤝 @OncoAlert 🚨 “Social Media & Virtual Meetings in the #COVID19 Era” survey?
Consider yourself lucky bc instead you can watch (‼️) #OncoAlert mastermind @weoncologists explain the whole thing in this (👇) @VJOncology video! https://twitter.com/vjoncology/status/1283072388209483777

VJ Oncology@VJOncology

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

#PYROTINIB EN #NSCLC AVANZADO HER2-MUTADO, PREVIO TRATAMIENTO CON #QUIMIOTERAPIA
https://www.esmo.org/oncology-news/pyrotinib-in-her2-mutated-advanced-nsclc-previously-treated-with-chemotherapy?hit=some

@Dunson30612519 @school_latin @GOncologia @ManuelDomine @MarianaBrandao0 @OPENoncology @susanahprieto @VJOncology @jillfeldman4 @dokter_onkologi @AnnaFaragoMD @myESMO https://twitter.com/myESMO/status/1282895118773686275

ESMO - Eur. Oncology@myESMO

Pyrotinib in HER2-mutated advanced #NSCLC previously treated with #chemotherapy: Promising antitumour activity & acceptable safety profile in #cancerpatients. A global, multicentre, randomised Ph3 III planned 🔎 http://ow.ly/4RcO50AwuT7 #oncologynews #cancerresearch #lcsm

Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’

Have your say here! 👉http://ow.ly/xWBb50Ay5wv👈

@weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter